EndoBarrier Technology
EndoBarrier™ technology is a proprietary platform of products for the treatment of type 2 diabetes and obesity. Importantly, EndoBarrier technology enables treatment to be individualized for the patient.
The EndoBarrier Gastrointestinal Liner works by creating a physical barrier between ingested food and the intestinal wall. Physicians believe this may change how hormonal signals that originate in the intestine are activated, mimicking the effects of gastric bypass procedure.
Weight loss is enhanced by combining the EndoBarrier Gastrointestinal Liner with the customizable EndoBarrier Flow Restrictor - both of which can be customized to meet individual patient needs. Preclinical studies have shown that combining the EndoBarrier Gastrointestinal Liner with the EndoBarrier Flow Restrictor affects multiple mechanisms of action.
Potential Benefits of the EndoBarrier Gastrointestinal Liner
- Mimics the effects of gastric bypass in resolution of type 2 diabetes
- Simultaneously facilitates weight loss
- Effects are immediate in improving glycemic control
- Reduces or eliminates other co-morbidities
- May eliminate or reduce reliance upon traditional therapies to treat type 2 diabetes and obesity
- May be used in conjunction with other therapeutic regimens for the treatment of type 2 diabetes and/or its co-morbidities
- Placed in a brief nonsurgical procedure and addresses patient fear of surgery
- Reversible procedure, with easy removal of device once desired effect has been attained
EndoBarrier technology is highly-advanced and at the forefront of type 2 diabetes and obesity treatment.
